🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Phase 1, Randomized, Double-blind, Three-arm, Parallel Group, Single-dose...
Status
Completed
Location
Phase 1 unit
Start Date
2020-05-28
Trial ID
NCT04018313
Treatments Being Tested
A single dose, double blind comparative trial to assess the pharmacokinetic...
Status
Completed
Location
Q-Pharm Pty Ltd
Start Date
2022-02-16
Trial ID
NCT05053334
Treatments Being Tested
The study is designed to explore the mode of action for omalizumab therapy ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-04
Trial ID
NCT01599637
A substance called immunoglobulin E (IgE), which is naturally produced by o...
Status
Completed
Location
Alabama Allergy and Asthma Center
Start Date
2004-04
Trial ID
NCT00079937
Treatments Being Tested
An open-label, randomized, in parallel groups comparative study of pharmaco...
Status
Completed
Location
State budgetary institution of health care of the city of Moscow "City outpatients clinic No. 2 of the Department of Health of the city of Moscow"
Start Date
2017-04-18
Trial ID
NCT04601389
Treatments Being Tested
The aim of this study was to characterize the real-world treatment patterns...
Status
Completed
Location
Novartis
Start Date
2026-03-10
Trial ID
NCT07450170
The purpose of this study is to determine the efficacy and safety of omaliz...
Status
Completed
Location
Jonathan Corren MD, Inc.
Start Date
2017-11-15
Trial ID
NCT03280550
Treatments Being Tested
Pragmatic trial to define the magnitude and the predictive factors of the r...
Status
Unknown
Location
Universitair Ziekenhuis Brussel
Start Date
2019-05-10
Trial ID
NCT03476109
Treatments Being Tested
The goal of this study is to examine the mechanism of action of omalizumab ...
Status
Completed
Location
Johns Hopkins Bayview Medical Center
Start Date
2020-12-15
Trial ID
NCT04583501
Treatments Being Tested
The study is a global Phase III, multicenter, randomized, double-blind, pla...
Status
Completed
Location
Multiple Locations
Start Date
2011-02
Trial ID
NCT01264939